Esperion Therapeutics
ESPR
$2.16
Share price
-5.68%
Change (1 day)
62.41%
Change (1 year)
Categories
Market capitalization of Esperion Therapeutics (ESPR)
Market cap: $0.40 Billion
As of June 2024 Esperion Therapeutics has a market cap of $0.40 Billion. This makes Esperion Therapeutics the world's 6252th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Esperion Therapeutics from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.40 B | 20.36% |
| 2023 | $0.34 B | -25.93% |
| 2022 | $0.45 B | 50.75% |
| 2021 | $0.30 B | -54.81% |
| 2020 | $0.67 B | -58.91% |
| 2019 | $1.63 B | 32.88% |
| 2018 | $1.23 B | -28.46% |
| 2017 | $1.72 B | 510.84% |
| 2016 | $0.28 B | -43.66% |
| 2015 | $0.50 B | -39.08% |
| 2014 | $0.82 B | 290.3% |
| 2013 | $0.21 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Esperion Therapeutics was reported to be:
$0.40 Billion
$0.40 Billion
$0.40 Billion
$0.40 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $162.40 B | 39,585.02% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $107.99 B | 26,290.77% | 🇺🇸 USA |
 Ultragenyx RARE | $3.33 B | 715.42% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.61 B | 50.17% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $2.90 B | 609.31% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $14.25 B | 3,383.17% | 🇺🇸 USA |